ARATANA THERAPEUTICS, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3f33e5ac-790e-43fb-8dbe-8acb547f8ca4/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2018 | $35.4M | 2018-01-01 – 2018-12-31 | evidence 0001509190-19-000018 |
| FY 2017 | $25.6M | 2017-01-01 – 2017-12-31 | evidence 0001509190-19-000018 |
| FY 2016 | $38.6M | 2016-01-01 – 2016-12-31 | evidence 0001509190-19-000018 |
| FY 2015 | $678.0k | 2015-01-01 – 2015-12-31 | evidence 0001509190-16-000061 |
| FY 2014 | $767.0k | 2014-01-01 – 2014-12-31 | evidence 0001509190-15-000005 |
| FY 2013 | $299.0k | 2010-12-01 – 2014-03-31 | evidence 0001193125-14-201485 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ARATANA THERAPEUTICS, INC. — all facts · Net Income · Operating Income